Our latest news

As part of the Nordic EMBL Partnership for Molecular Medicine (NEP), the Norwegian Centre for Molecular Biosciences and Medicine (NCMBM) recently hosted a two-day workshop in Oslo titled “Shaping Culture: Training for an Inclusive and Collaborative Research Environment.”

PhD student Iga Niemiec and postdoctoral fellow Ladislav Hovan on their UiO:Life Science Internationalisation experiences.

In this interview, we caught up with Charlène Sueur, a NORPOD fellow whose work focuses on understanding how gene regulatory elements drive colorectal cancer progression and therapy resistance. She is working with Biswajyoti Sahu at NCMBM and Arafath (Rafa) Najumudeen at FIMM.

Researchers uncover how loss of a gene called MAP4K1 amplifies T cell responses, offering insights into immune disorders and potential therapies.

We spoke with Lei Xia, one of the new NORPOD Fellows about their ambitious research project, international collaborations, and what motivates their journey into cancer epigenetics and machine learning. Lei Xia is working with Esa Pitkänen at FIMM and Biswajyoti Sahu at NCMBM.

We are excited to welcome Fiona Müllner as a new Group Leader at DANDRITE, bringing in a unique approach to neural circuitry and sensory processing.

Professor Olli Kallioniemi has been awarded a €2 500 000 Brain Gain grant for research into artificial intelligence in medicine. The five-year grant will enable Kallioniemi to establish a research group at the Institute for Molecular Medicine Finland (FIMM) at the University of Helsinki gradually, during 2024-2025.

We are very happy to announce that the three top candidates for the FIMM-EMBL Group Leader positions have all accepted the offer to join FIMM. Please welcome Nina Mars, Arafath (Rafa) Najumudeen and Simone Rubinacci!